https://www.onclive.com/login?redirect=onclive-tv/dr-anders-discusses-the-use-of-neratinibcapecitabine-for-her2positive-brain-metastases/

Key Trials Showcase the Utility of Neratinib in HER2+ Breast Cancer

https://www.onclive.com/web-exclusives/key-trials-showcase-the-utility-of-neratinib-in-her2-positive-breast-cancer?p=1

Neratinib Approved in Canada for Early-Stage HER2+ Breast Cancer

https://www.onclive.com/web-exclusives/neratinib-approved-in-canada-for-early-stage-her2-positive-breast-cancer

Dr. Traina on Conversations on Extended Adjuvant Therapy With Neratinib in HER2+ Breast Cancer

https://www.onclive.com/publications/priority-report/2019/management-of-diarrhea/dr-traina-on-conversations-on-extended-adjuvant-therapy-with-neratinib-in-her2-breast-cancer/

At ASCO 2019, New Studies Provide Hope for Patients With Metastatic Breast Cancer

https://www.medscape.com/viewarticle/915413

HER2+ Breast Cancer: Neratinibs Role as Adjuvant Therapy

https://www.onclive.com/peer-exchange/sabcs-evolving-treatment-patterns/her2-breast-cancer-neratinibs-role-as-adjuvant-therapy

Dr. Esteva Discusses Neratinib Updates in HER2+ Breast Cancer

https://www.onclive.com/onclive-tv/dr-esteva-discusses-neratinib-updates-in-her2-breast-cancer

EMA approves neratinib for early breast cancer

https://www.onclive.com/web-exclusives/neratinib-approaches-eu-approval-for-her2-breast-cancer

https://www.onclive.com/inside-oncology/conference-broadcast-breast2018/the-extenet-trial